ARCHIVES

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

This article is from The Cancer Letter archive.

Vol. 31 No. 18 | May 6, 2005

Download PDF Visit The Full Archive

Related Articles

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

In Brief: Fox Chase Joins Temple Health System, Expands Outpatient and Surgical Services

July 6, 2012

In Brief: Clinton Backs Ban On Human Cloning; Wisconsin Selects Niederhuber As Director

June 13, 1997

NCI Names 15 to Director’s Consumer Liaison Group.

January 14, 2005

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

August 3, 2001

Obama Reiterates Support For Doubling Budgets For Cancer Research, Other Science Agencies

May 1, 2009